|
CO-ADMINISTRATION OF DIGOXIN AND SYMPATHOMIMETICS INCREASES THE RISK OF CARDIAC ARRHYTHMIAS
|
CO-ADMINISTRATION OF DIGOXIN AND SYMPATHOMIMETICS INCREASES THE RISK OF CARDIAC ARRHYTHMIAS
|
LEVODOPA EFFECTS ARE ENHANCED BY THE DRUG
|
AMPHETAMINES MAY DELAY INTESTINAL ABSORPTION OF THE DRUG
|
AMPHETAMINES MAY DELAY INTESTINAL ABSORPTION OF THE DRUG
|
LITHIUM INHIBITS THE ANORECTIC AND STIMULATORY EFFECTS OF AMPHETAMINE
|
LITHIUM INHIBITS THE ANORECTIC AND STIMULATORY EFFECTS OF AMPHETAMINE
|
SYMPATHOMIMETICS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
SYMPATHOMIMETICS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
SYMPATHOMIMETICS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
SYMPATHOMIMETICS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
SYMPATHOMIMETICS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
AMPHETAMINE INHIBITS ADRENERGIC BLOCKERS AND CONCURRENT USE OF BETABLOCKERS AND AMPHETAMINE MAY PRODUCE SEVERE HYPERTENSION
|
HALOPERIDOL BLOCKS DOPAMINE RECEPTORS, THUS INHIBITING THE CENTRAL STIMULAT EFFECTS OF AMPHETAMINE
|
BETABLOCKERS CONCOMITANT USE MAY CAUSE SEVERE HYPERTENSION SINCE BETABLOCKERS OPPOSE THE BETA ADRENERGIC ACTION OF SYMPATHOMIMETICS
|
BETABLOCKERS CONCOMITANT USE MAY CAUSE SEVERE HYPERTENSION SINCE BETABLOCKERS OPPOSE THE BETA ADRENERGIC ACTION OF SYMPATHOMIMETICS
|
BETABLOCKERS CONCOMITANT USE MAY CAUSE SEVERE HYPERTENSION SINCE BETABLOCKERS OPPOSE THE BETA ADRENERGIC ACTION OF SYMPATHOMIMETICS
|
BETABLOCKERS CONCOMITANT USE MAY CAUSE SEVERE HYPERTENSION SINCE BETABLOCKERS OPPOSE THE BETA ADRENERGIC ACTION OF SYMPATHOMIMETICS
|
BETABLOCKERS CONCOMITANT USE MAY CAUSE SEVERE HYPERTENSION SINCE BETABLOCKERS OPPOSE THE BETA ADRENERGIC ACTION OF SYMPATHOMIMETICS
|
BETABLOCKERS CONCOMITANT USE MAY CAUSE SEVERE HYPERTENSION SINCE BETABLOCKERS OPPOSE THE BETA ADRENERGIC ACTION OF SYMPATHOMIMETICS
|
BETABLOCKERS CONCOMITANT USE MAY CAUSE SEVERE HYPERTENSION SINCE BETABLOCKERS OPPOSE THE BETA ADRENERGIC ACTION OF SYMPATHOMIMETICS
|
BETABLOCKERS CONCOMITANT USE MAY CAUSE SEVERE HYPERTENSION SINCE BETABLOCKERS OPPOSE THE BETA ADRENERGIC ACTION OF SYMPATHOMIMETICS
|
BETABLOCKERS CONCOMITANT USE MAY CAUSE SEVERE HYPERTENSION SINCE BETABLOCKERS OPPOSE THE BETA ADRENERGIC ACTION OF SYMPATHOMIMETICS
|
BETABLOCKERS CONCOMITANT USE MAY CAUSE SEVERE HYPERTENSION SINCE BETABLOCKERS OPPOSE THE BETA ADRENERGIC ACTION OF SYMPATHOMIMETICS
|
BETABLOCKERS CONCOMITANT USE MAY CAUSE SEVERE HYPERTENSION SINCE BETABLOCKERS OPPOSE THE BETA ADRENERGIC ACTION OF SYMPATHOMIMETICS
|
SYMPATHOMIMETICS HYPERTENSIVE EFFECT IS POTENTIATED BY THE TRICYCLIC ANTIDEPRESSANTS LEADING TO PROLONGED SEVERE HYPERTENSION
|
SYMPATHOMIMETICS HYPERTENSIVE EFFECT IS POTENTIATED BY THE TRICYCLIC ANTIDEPRESSANTS LEADING TO PROLONGED SEVERE HYPERTENSION
|
SYMPATHOMIMETICS HYPERTENSIVE EFFECT IS POTENTIATED BY THE TRICYCLIC ANTIDEPRESSANTS LEADING TO PROLONGED SEVERE HYPERTENSION
|
PHENOTHIAZINES LIKE CHLORPROMAZINE, PROMETHAZINE BLOCK DOPAMINE & NOREPINEPHRINE RECEPTORS, THUS INHIBITING THE CENTRAL STIMULATING EFFECTS OF AMPHETAMINES AND CAN BE USED TO TREAT AMPHETAMINE POISONING
|
PHENOTHIAZINES LIKE CHLORPROMAZINE, PROMETHAZINE BLOCK DOPAMINE & NOREPINEPHRINE RECEPTORS, THUS INHIBITING THE CENTRAL STIMULATING EFFECTS OF AMPHETAMINES AND CAN BE USED TO TREAT AMPHETAMINE POISONING
|
PHENOTHIAZINES LIKE CHLORPROMAZINE, PROMETHAZINE BLOCK DOPAMINE & NOREPINEPHRINE RECEPTORS, THUS INHIBITING THE CENTRAL STIMULATING EFFECTS OF AMPHETAMINES AND CAN BE USED TO TREAT AMPHETAMINE POISONING
|
PHENOTHIAZINES LIKE CHLORPROMAZINE, PROMETHAZINE BLOCK DOPAMINE & NOREPINEPHRINE RECEPTORS, THUS INHIBITING THE CENTRAL STIMULATING EFFECTS OF AMPHETAMINES AND CAN BE USED TO TREAT AMPHETAMINE POISONING
|
PHENOTHIAZINES LIKE CHLORPROMAZINE, PROMETHAZINE BLOCK DOPAMINE & NOREPINEPHRINE RECEPTORS, THUS INHIBITING THE CENTRAL STIMULATING EFFECTS OF AMPHETAMINES AND CAN BE USED TO TREAT AMPHETAMINE POISONING
|
PHENOTHIAZINES LIKE CHLORPROMAZINE, PROMETHAZINE BLOCK DOPAMINE & NOREPINEPHRINE RECEPTORS, THUS INHIBITING THE CENTRAL STIMULATING EFFECTS OF AMPHETAMINES AND CAN BE USED TO TREAT AMPHETAMINE POISONING
|
PHENOTHIAZINES LIKE CHLORPROMAZINE, PROMETHAZINE BLOCK DOPAMINE & NOREPINEPHRINE RECEPTORS, THUS INHIBITING THE CENTRAL STIMULATING EFFECTS OF AMPHETAMINES AND CAN BE USED TO TREAT AMPHETAMINE POISONING
|
PHENOTHIAZINES LIKE CHLORPROMAZINE, PROMETHAZINE BLOCK DOPAMINE & NOREPINEPHRINE RECEPTORS, THUS INHIBITING THE CENTRAL STIMULATING EFFECTS OF AMPHETAMINES AND CAN BE USED TO TREAT AMPHETAMINE POISONING
|
AMPHETAMINE MAY REDUCE THE HYPOTENSIVE EFFECTS OF ANTIHYPERTENSIVES INCLUDING BETABLOCKERS
|
AMPHETAMINE MAY REDUCE THE HYPOTENSIVE EFFECTS OF ANTIHYPERTENSIVES INCLUDING BETABLOCKERS
|
AMPHETAMINE MAY REDUCE THE HYPOTENSIVE EFFECTS OF ANTIHYPERTENSIVES INCLUDING BETABLOCKERS
|
AMPHETAMINE MAY REDUCE THE HYPOTENSIVE EFFECTS OF ANTIHYPERTENSIVES INCLUDING BETABLOCKERS
|
AMPHETAMINE MAY REDUCE THE HYPOTENSIVE EFFECTS OF ANTIHYPERTENSIVES INCLUDING BETABLOCKERS
|
AMPHETAMINE MAY REDUCE THE HYPOTENSIVE EFFECTS OF ANTIHYPERTENSIVES INCLUDING BETABLOCKERS
|
AMPHETAMINE MAY REDUCE THE HYPOTENSIVE EFFECTS OF ANTIHYPERTENSIVES INCLUDING BETABLOCKERS
|
AMPHETAMINE MAY REDUCE THE HYPOTENSIVE EFFECTS OF ANTIHYPERTENSIVES INCLUDING BETABLOCKERS
|
MAOI INHIBIT THE METABOLISM OF SYMPATHOMIMETICS WHICH CAN LEAD TO DANGEROUS ENHANCEMENT OF THEIR PRESSOR EFFECTS CAUSING HEADACHE, HIGH BLOOD PRESSURE / HYPERTENSIVE CRISIS. A VARIETY OF NEUROLOGICAL TOXIC EFFECTS & MALIGNANT HYPERPYREXIA CAN OCCUR
|
MAOI INHIBIT THE METABOLISM OF SYMPATHOMIMETICS WHICH CAN LEAD TO DANGEROUS ENHANCEMENT OF THEIR PRESSOR EFFECTS CAUSING HEADACHE, HIGH BLOOD PRESSURE / HYPERTENSIVE CRISIS. A VARIETY OF NEUROLOGICAL TOXIC EFFECTS & MALIGNANT HYPERPYREXIA CAN OCCUR
|
MAOI INHIBIT THE METABOLISM OF SYMPATHOMIMETICS WHICH CAN LEAD TO DANGEROUS ENHANCEMENT OF THEIR PRESSOR EFFECTS CAUSING HEADACHE, HIGH BLOOD PRESSURE / HYPERTENSIVE CRISIS. A VARIETY OF NEUROLOGICAL TOXIC EFFECTS & MALIGNANT HYPERPYREXIA CAN OCCUR
|
MAOI INHIBIT THE METABOLISM OF SYMPATHOMIMETICS WHICH CAN LEAD TO DANGEROUS ENHANCEMENT OF THEIR PRESSOR EFFECTS CAUSING HEADACHE, HIGH BLOOD PRESSURE / HYPERTENSIVE CRISIS. A VARIETY OF NEUROLOGICAL TOXIC EFFECTS & MALIGNANT HYPERPYREXIA CAN OCCUR
|
AMPHETAMINES CAN ENHANCE THE ACTIVITY OF SYMPATHOMIMETIC AGENTS
|
AMPHETAMINES CAN ENHANCE THE ACTIVITY OF SYMPATHOMIMETIC AGENTS
|
AMPHETAMINES CAN ENHANCE THE ACTIVITY OF SYMPATHOMIMETIC AGENTS
|
AMPHETAMINES CAN ENHANCE THE ACTIVITY OF SYMPATHOMIMETIC AGENTS
|
AMPHETAMINES CAN ENHANCE THE ACTIVITY OF SYMPATHOMIMETIC AGENTS
|
AMPHETAMINES CAN ENHANCE THE ACTIVITY OF SYMPATHOMIMETIC AGENTS
|
AMPHETAMINES CAN ENHANCE THE ACTIVITY OF SYMPATHOMIMETIC AGENTS
|
AMPHETAMINES CAN ENHANCE THE ACTIVITY OF SYMPATHOMIMETIC AGENTS
|
AMPHETAMINES CAN ENHANCE THE ACTIVITY OF SYMPATHOMIMETIC AGENTS
|
AMPHETAMINES CAN ENHANCE THE ACTIVITY OF SYMPATHOMIMETIC AGENTS
|
AMPHETAMINES CAN ENHANCE THE ACTIVITY OF SYMPATHOMIMETIC AGENTS
|
AMPHETAMINES CAN ENHANCE THE ACTIVITY OF SYMPATHOMIMETIC AGENTS
|
AMPHETAMINES CAN ENHANCE THE ACTIVITY OF SYMPATHOMIMETIC AGENTS
|
AMPHETAMINES CAN ENHANCE THE ACTIVITY OF SYMPATHOMIMETIC AGENTS
|
AMPHETAMINES CAN ENHANCE THE ACTIVITY OF SYMPATHOMIMETIC AGENTS
|
AMPHETAMINES CAN ENHANCE THE ACTIVITY OF SYMPATHOMIMETIC AGENTS
|
AMPHETAMINES CAN ENHANCE THE ACTIVITY OF SYMPATHOMIMETIC AGENTS
|
AMPHETAMINES CAN ENHANCE THE ACTIVITY OF SYMPATHOMIMETIC AGENTS
|
AMPHETAMINES CAN ENHANCE THE ACTIVITY OF SYMPATHOMIMETIC AGENTS
|
AMPHETAMINES CAN ENHANCE THE ACTIVITY OF SYMPATHOMIMETIC AGENTS
|
AMPHETAMINES CAN ENHANCE THE ACTIVITY OF SYMPATHOMIMETIC AGENTS
|
MAOIS INHIBIT THE DRUG METABOLIZING ENZYMES, WHICH MAY ENHANCE THE EFFECTS OF BARBITURATE, HYPNOTICS, HYPOGLYCAENICS & ANTIMUSCARINICS
|
PHENOTHIAZINES LIKE CHLORPROMAZINE, PROMETHAZINE BLOCK DOPAMINE & NOREPINEPHRINE RECEPTORS, THUS INHIBITING THE CENTRAL STIMULATING EFFECTS OF AMPHETAMINES AND CAN BE USED TO TREAT AMPHETAMINE POISONING
|
PHENOTHIAZINES LIKE CHLORPROMAZINE, PROMETHAZINE BLOCK DOPAMINE & NOREPINEPHRINE RECEPTORS, THUS INHIBITING THE CENTRAL STIMULATING EFFECTS OF AMPHETAMINES AND CAN BE USED TO TREAT AMPHETAMINE POISONING
|
PHENOTHIAZINES LIKE CHLORPROMAZINE, PROMETHAZINE BLOCK DOPAMINE & NOREPINEPHRINE RECEPTORS, THUS INHIBITING THE CENTRAL STIMULATING EFFECTS OF AMPHETAMINES AND CAN BE USED TO TREAT AMPHETAMINE POISONING
|
PHENOTHIAZINES LIKE CHLORPROMAZINE, PROMETHAZINE BLOCK DOPAMINE & NOREPINEPHRINE RECEPTORS, THUS INHIBITING THE CENTRAL STIMULATING EFFECTS OF AMPHETAMINES AND CAN BE USED TO TREAT AMPHETAMINE POISONING
|
PHENOTHIAZINES LIKE CHLORPROMAZINE, PROMETHAZINE BLOCK DOPAMINE & NOREPINEPHRINE RECEPTORS, THUS INHIBITING THE CENTRAL STIMULATING EFFECTS OF AMPHETAMINES AND CAN BE USED TO TREAT AMPHETAMINE POISONING
|
PHENOTHIAZINES LIKE CHLORPROMAZINE, PROMETHAZINE BLOCK DOPAMINE & NOREPINEPHRINE RECEPTORS, THUS INHIBITING THE CENTRAL STIMULATING EFFECTS OF AMPHETAMINES AND CAN BE USED TO TREAT AMPHETAMINE POISONING
|
PHENOTHIAZINES LIKE CHLORPROMAZINE, PROMETHAZINE BLOCK DOPAMINE & NOREPINEPHRINE RECEPTORS, THUS INHIBITING THE CENTRAL STIMULATING EFFECTS OF AMPHETAMINES AND CAN BE USED TO TREAT AMPHETAMINE POISONING
|
PHENOTHIAZINES LIKE CHLORPROMAZINE, PROMETHAZINE BLOCK DOPAMINE & NOREPINEPHRINE RECEPTORS, THUS INHIBITING THE CENTRAL STIMULATING EFFECTS OF AMPHETAMINES AND CAN BE USED TO TREAT AMPHETAMINE POISONING
|
PHENOTHIAZINES LIKE CHLORPROMAZINE, PROMETHAZINE BLOCK DOPAMINE & NOREPINEPHRINE RECEPTORS, THUS INHIBITING THE CENTRAL STIMULATING EFFECTS OF AMPHETAMINES AND CAN BE USED TO TREAT AMPHETAMINE POISONING
|
PHENOTHIAZINES LIKE CHLORPROMAZINE, PROMETHAZINE BLOCK DOPAMINE & NOREPINEPHRINE RECEPTORS, THUS INHIBITING THE CENTRAL STIMULATING EFFECTS OF AMPHETAMINES AND CAN BE USED TO TREAT AMPHETAMINE POISONING
|
PHENOTHIAZINES LIKE CHLORPROMAZINE, PROMETHAZINE BLOCK DOPAMINE & NOREPINEPHRINE RECEPTORS, THUS INHIBITING THE CENTRAL STIMULATING EFFECTS OF AMPHETAMINES AND CAN BE USED TO TREAT AMPHETAMINE POISONING
|
PHENOTHIAZINES LIKE CHLORPROMAZINE, PROMETHAZINE BLOCK DOPAMINE & NOREPINEPHRINE RECEPTORS, THUS INHIBITING THE CENTRAL STIMULATING EFFECTS OF AMPHETAMINES AND CAN BE USED TO TREAT AMPHETAMINE POISONING
|
PHENOTHIAZINES LIKE CHLORPROMAZINE, PROMETHAZINE BLOCK DOPAMINE & NOREPINEPHRINE RECEPTORS, THUS INHIBITING THE CENTRAL STIMULATING EFFECTS OF AMPHETAMINES AND CAN BE USED TO TREAT AMPHETAMINE POISONING
|
PHENOTHIAZINES LIKE CHLORPROMAZINE, PROMETHAZINE BLOCK DOPAMINE & NOREPINEPHRINE RECEPTORS, THUS INHIBITING THE CENTRAL STIMULATING EFFECTS OF AMPHETAMINES AND CAN BE USED TO TREAT AMPHETAMINE POISONING
|
PHENOTHIAZINES LIKE CHLORPROMAZINE, PROMETHAZINE BLOCK DOPAMINE & NOREPINEPHRINE RECEPTORS, THUS INHIBITING THE CENTRAL STIMULATING EFFECTS OF AMPHETAMINES AND CAN BE USED TO TREAT AMPHETAMINE POISONING
|
PHENOTHIAZINES LIKE CHLORPROMAZINE, PROMETHAZINE BLOCK DOPAMINE & NOREPINEPHRINE RECEPTORS, THUS INHIBITING THE CENTRAL STIMULATING EFFECTS OF AMPHETAMINES AND CAN BE USED TO TREAT AMPHETAMINE POISONING
|
PHENOTHIAZINES LIKE CHLORPROMAZINE, PROMETHAZINE BLOCK DOPAMINE & NOREPINEPHRINE RECEPTORS, THUS INHIBITING THE CENTRAL STIMULATING EFFECTS OF AMPHETAMINES AND CAN BE USED TO TREAT AMPHETAMINE POISONING
|
AMPHETAMINES MAY DELAY INTESTINAL ABSORPTION OF THE DRUG. CONCURRENT USE MAY PRODUCE A SYNERGISTIC ANTICONVULSANT ACTION
|
AMPHETAMINES MAY DELAY INTESTINAL ABSORPTION OF THE DRUG. CONCURRENT USE MAY PRODUCE A SYNERGISTIC ANTICONVULSANT ACTION
|
AMPHETAMINES MAY DELAY INTESTINAL ABSORPTION OF THE DRUG. CONCURRENT USE MAY PRODUCE A SYNERGISTIC ANTICONVULSANT ACTION
|
AMPHETAMINES MAY DELAY INTESTINAL ABSORPTION OF THE DRUG. CONCURRENT USE MAY PRODUCE A SYNERGISTIC ANTICONVULSANT ACTION
|
AMPHETAMINES MAY DELAY INTESTINAL ABSORPTION OF THE DRUG. CONCURRENT USE MAY PRODUCE A SYNERGISTIC ANTICONVULSANT ACTION
|
AMPHETAMINES MAY DELAY INTESTINAL ABSORPTION OF THE DRUG. CONCURRENT USE MAY PRODUCE A SYNERGISTIC ANTICONVULSANT ACTION
|
AMPHETAMINE CNS STIMULATION IS POTENTIATED & FATAL CONVULSIONS CAN OCCUR IN CASES OF PROPOXYPHENE OVERDOSE
|